Erectile Dysfunction A Prospective Randomized Placebo-Controlled Study Evaluating the Effect of Low-Intensity...

Area of Science:

• Urology
• Andrology
• Sexual Medicine

Background:

• Erectile dysfunction (ED) is a common complication following robotic nerve-sparing radical prostatectomy (RARP).
• Low-intensity extracorporeal shockwave therapy (Li-ESWT) has shown potential in improving vascular-related ED.
• Penile rehabilitation strategies are crucial for post-prostatectomy recovery.

Purpose of the Study:

• To evaluate the efficacy of Li-ESWT for penile rehabilitation in men with ED post-RARP.
• To assess sexual outcomes using validated questionnaires and scoring systems.
• To conduct a randomized, placebo-controlled trial to determine treatment effectiveness.

Main Methods:

• A randomized, placebo-controlled trial involving 38 men with ED post-nerve-sparing RP (IIEF-5 score <22).
• Participants were assigned to either active Li-ESWT (n=20) or placebo/sham (n=18) treatment.
• Treatments consisted of one session per week for five weeks, with assessments at baseline, 4, and 12 weeks.

Main Results:

• Significant improvements in the International Index of Erectile Function (IIEF-5) and Erection Hardness Score (EHS) were observed in the active Li-ESWT group.
• At 12 weeks post-treatment, the mean IIEF-5 score increased by 3.45 points (P = .026).
• The mean EHS score increased by 0.5 points at 12 weeks (P = .019) in the Li-ESWT group.

Conclusions:

• Li-ESWT appears to be a safe and potentially effective treatment for ED in men following RARP.
• The study suggests Li-ESWT can aid in penile rehabilitation after prostatectomy.
• Further robust research is necessary to establish Li-ESWT as a definitive treatment modality for post-prostatectomy ED.